Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04110808
Other study ID # hypotensive anaesthesia
Secondary ID
Status Not yet recruiting
Phase Early Phase 1
First received
Last updated
Start date October 15, 2019
Est. completion date February 1, 2020

Study information

Verified date September 2019
Source Beni-Suef University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

AIM OF THE WORK The aim of this work was to compare the effect of hypotensive anaesthesia using Nitroglycerine versus phentolamine on Event related potentials, quantitative Electroencephalograghy and cognitive function, in patients undergoing septoplasty.


Description:

METHODS:

Study design and population: This is a pilot prospective randomized clinical trial that will be carried out on 60 patients candidate for septoplasty subjected to general hypotensive anaesthesia. The patients will be recruited from Ear, nose and throat surgery department, Beni-Suef University Hospital. All the participants will be required to offer a written informed consent

Sampling Technique:

Patients will be randomly assigned into one of two equal groups; the first group will receive nitroglycerine (30 participants) (nitroglycerine group) and the second group will receive phentolamine (30 participants) (phentolamine group). Randomization will be carried out using a closed opaque envelope technique with the anesthetist will pick up a sealed envelope which contains a paper with the name of the group to which the patient will be randomized is written. Whichever the group written on the paper, the patient will be scheduled to it.

All included patients will be subjected to the following:

1) Cognitive assessment:

Cognitive functions for the patients will be assessed (preoperative and 1 week postoperative) using the following psychometric tests:

1. Paired Associate Learning test (PALT) Aim: to assess auditory verbal memory. The test uses the concept of semantic cueing

.

2. Benton Visual Retention test (BVRT) Aim: to assess visual perceptual, visual memory, visual motor and visuoconstructive abilities.

2) Neurophysiological assessment: Digital Electroencephalograghy (EEG), quantitative Electroencephalograghy (QEEG) and Event related potentials (ERPs) and will be done for all included patients (preoperative and 1 week postoperative).

Statistical analysis The sample size will be calculated using G*Power version 3.1.9.2 Software based on this pilot study. The probability of type I error (α) will be 5%, and the statistical power (1-β) should exceed 80%. The data will be coded and entered using: the statistical package for social science version 15 (SPSS v 15). Descriptive statistics will be reported as mean ± SD and number (%) for categorical variables. Student t- test will be used for comparison between means of two unpaired groups of quantitative variables. Paired sample t- test will be used for comparison between means of two paired groups of quantitative variables. Chi square test will be used for comparison between two groups of categorical data. Mixed ANOVA test will be used for comparing paired data in two unpaired groups. The probability/significance value (P value) ≥ 0.05 is not statistically significant and <0.05 is statistically significant.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 60
Est. completion date February 1, 2020
Est. primary completion date January 1, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years to 50 Years
Eligibility Inclusion Criteria:

- Patients who are candidate for septoplasty

- Patients from both sexes, aged between 20-50 years

Exclusion Criteria:

- Patients who develop intraoperative shock or major bleeding

- Patients with ischemic heart diseases, heart block, congestive heart failure, valvular heart diseases, or uncontrolled hypertension

- Patients with a history of central neurological system disorder

- Patients with concomitant medical or metabolic illness known to affect cognition

- Pregnant females

- Allergy to any of the anaesthetic or hypotensive drugs used in the study

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
hypotensive anaesthesia using Nitroglycerine
effect of hypotensive anaesthesia using Nitroglycerine vs Phentolamine on Event related potentials, quantitative Electroencephalograghy and cognitive function Phentolamine group (30 patients): Patients will receive hypotensive anesthesia with phentolamine infusion via syringe pump by adding 20 mg (2ml) of Phentolamine to 48 ml of normal saline making it to final concentration of 0.4 mg/ml at the rate of 0.1-2 mg/min according to the patients desired target blood pressure. Nitroglycerine group (30 patients): Patients will receive hypotensive anesthesia with nitroglycerine infusion via syringe pump by adding 5mg (5ml) of Nitroglycerin to 45ml of normal saline making it to final concentration of 100µg/ml at the rate of 0.5- 10 µg/kg/min according to the patients desired target blood pressure.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Beni-Suef University

Outcome

Type Measure Description Time frame Safety issue
Primary Paired Associate Learning test for assessment of Cognitive function Comparative effect of hypotensive anaesthesia using Nitroglycerine vs Phentolamine 1 week
Primary Benton Visual Retention test for assessment of Cognitive function Comparative effect of hypotensive anaesthesia using Nitroglycerine vs Phentolamine 1 week
Secondary Quantitative Electroencephalograghy for assessment of electrical activity of the brain Comparative effect of hypotensive anaesthesia using Nitroglycerine vs Phentolamine 1 week
Secondary Event related potentials (ERP ) P300 for neurophysiological assessment of cognition Comparative effect of hypotensive anaesthesia using Nitroglycerine vs Phentolamine 1 week
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03683953 - The Treatment of Bronchopulmonary Dysplasia by Intratracheal Instillation of Mesenchymal Stem Cells Phase 1
Not yet recruiting NCT04554589 - The Off Label Use of Glycopyrrolate in the Adults Intensive Care Unit. Phase 1
Completed NCT04170088 - Comparison of Efficacy of Tranexamic Acid Mesotherapy Versus 0.9% Normal Saline for Melasma Phase 2/Phase 3
Suspended NCT03995004 - The Effect of Melatonin on Postoperative Pain Reduction After Orthognathic Surgery Phase 1
Terminated NCT04296838 - Effects of Conbercept in Refractory Uveitic Macular Edema and VEGF Phase 2/Phase 3
Recruiting NCT03791372 - Clinical Effect and Safety of Autologous Umbilical Cord Blood Transfusion in the Treatment of Cerebral Palsy Phase 1
Completed NCT04027543 - Neoadjuvant Chemotherapy or Chemoradiotherapy in Resectable Oesophageal Carcinoma(NewEC Study)
Not yet recruiting NCT03696745 - The Treatment of Premature Infants With Brain Injury by Autologous Umbilical Cord Blood Stem Cells Phase 1
Recruiting NCT03120273 - A Clinical Trial to Evaluate the Safety and Tolerability of Dexlansoprazole Injection in Healthy Chinese Adults(Part 2) Phase 1
Unknown status NCT01633099 - Therapeutic Effect and Safety Study of Decitabine in Elderly Acute Myeloid Leukemia Patients Phase 3
Completed NCT05311540 - Zinc Supplementation In Very Low Birth Weight Infants-A Randomised Controlled Trial Phase 4
Completed NCT03488186 - PK-PD Comparative Study of Lansoprazole Capsules and Lansoprazole Enteric-coated Capsules in Healthy Chinese Volunteers Phase 1
Recruiting NCT04042597 - Anlotinib Hydrochloride Versus Imatinib Mesylate in Locally Advanced, Unresectable or Metastatic Chordoma Phase 2
Completed NCT03339882 - Remifemin Preventing the Climacteric Symptoms in Breast Cancer Phase 2
Completed NCT03760900 - Safety of Autologous Cord Blood Cells for Preterm Infants. Early Phase 1
Recruiting NCT03053076 - Safety and Efficacy of Autologous Umbilical Cord Blood Mononuclear Cells Transfusion in Neonates Phase 1
Recruiting NCT04326504 - Dolutegravir and Clinical Outcomes Among ART-recipients in Brazil
Recruiting NCT03700177 - Ropivacaine 0,2% Plus Dexamethasone Versus Ropivacaine 0,2% Plus Placebo in Modified Pectoral Block Phase 4
Completed NCT03228836 - Efficacy and Safety Evaluation of IBI308 in Patients With Extranodal NK/T Cell Lymphoma Patients Phase 2
Not yet recruiting NCT03600506 - Dexmedetomidine Adjuvant to General Anesthesia of Abdominal Hysterectomy N/A